Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A brief review of urate transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia and gout: Current therapeutic options and potential applications
Danni Song, Xu Zhao, Fuqi Wang, et al.
European Journal of Pharmacology (2021) Vol. 907, pp. 174291-174291
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Reducing hyperuricemic events with SGLT2 inhibitors: An updated systematic review with meta-regression
Hamlet Ghukasyan, Denilsa Navalha, Ignacio Pérez Romero, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2025) Vol. 72, Iss. 1, pp. 26-36
Closed Access | Times Cited: 1
Structural Basis for Inhibition of Urate Reabsorption in URAT1
Junping Fan, Wenjun Xie, Han Ke, et al.
JACS Au (2025) Vol. 5, Iss. 3, pp. 1308-1319
Open Access | Times Cited: 1
Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes
Jiandong Zhou, Xuejin Liu, Oscar Hou In Chou, et al.
Lara D. Veeken (2022) Vol. 62, Iss. 4, pp. 1501-1510
Closed Access | Times Cited: 31
Ethanolic Extract from Limonia acidissima L. Fruit Attenuates Serum Uric Acid Level via URAT1 in Potassium Oxonate-Induced Hyperuricemic Rats
Rika Yusnaini, Rosnani Nasution, Nurdin Saidi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 419-419
Open Access | Times Cited: 18
Protecting against ferroptosis in hyperuricemic nephropathy: The potential of ferrostatin-1 and its inhibitory effect on URAT1
Yongmei Li, Fengxin Zheng, Shiqi Zhong, et al.
European Journal of Pharmacology (2024) Vol. 971, pp. 176528-176528
Closed Access | Times Cited: 7
Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia
Fengxin Zheng, Suiqing Mai, Xiaolin Cen, et al.
Bioorganic Chemistry (2024) Vol. 147, pp. 107381-107381
Closed Access | Times Cited: 6
Structural basis for the transport and substrate selection of human urate transporter 1
Jingjing He, Guoyun Liu, Fang Kong, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114628-114628
Open Access | Times Cited: 6
Plantaginis Semen Ameliorates Hyperuricemia Induced by Potassium Oxonate
Tian Liu, Liting Wang, Li Ji, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8548-8548
Open Access | Times Cited: 5
Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2020–present)
Xiaoyu Shi, Tong Zhao, Edeildo Ferreira da Silva‐Júnior, et al.
Expert Opinion on Therapeutic Patents (2022) Vol. 32, Iss. 12, pp. 1175-1184
Closed Access | Times Cited: 22
Hypouricemic effect of gallic acid, a bioactive compound fromSonneratia apetalaleaves and branches, on hyperuricemic mice
Linyun Jiang, Yulin Wu, Chang Qu, et al.
Food & Function (2022) Vol. 13, Iss. 19, pp. 10275-10290
Closed Access | Times Cited: 20
Ameliorative Effect of Mannuronate Oligosaccharides on Hyperuricemic Mice via Promoting Uric Acid Excretion and Modulating Gut Microbiota
Biqian Wei, Pengfei Ren, Ruzhen Yang, et al.
Nutrients (2023) Vol. 15, Iss. 2, pp. 417-417
Open Access | Times Cited: 13
Loss of Urat1 exacerbates APAP-induced liver injury in mice
Kunlu Zhao, Shuaishuai Zhang, Jinhong Tian, et al.
Toxicology (2025), pp. 154070-154070
Closed Access
Oleanolic Acid Alleviates Hyperuricemia via Gut Microbiota Control the Integrity of Gut Barrier and the Expressions of Urate Transporter in Mice
Tingting Zhang, Siyan Liu, Shenlin Liu, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Benzbromarone Analog SAR: Potent hURAT1 (SLC22A12) Inhibitors and Drug Transporter Interaction Studies
Promsuk Jutabha, Vijay Kumar, Naohiko Anzai, et al.
Drug Design Development and Therapy (2025) Vol. Volume 19, pp. 1377-1392
Open Access
A promising strategy for assessing the uricosuric effect of anti-hyperuricemia candidates: a case study of caffeoylquinic acids extract of Artemisia selengensis Turcz. leaves
Xiang Lin, Mohammed Mansour, Yuting Huang, et al.
Food, Nutrition and Health. (2025) Vol. 2, Iss. 1
Open Access
Molecular mechanisms of saffron petals in the treatment of hyperuricemia: a network pharmacology and experimental verifcation study
Na Chen, Jiaqi Li, Xue Zhang, et al.
South African Journal of Botany (2025) Vol. 180, pp. 653-667
Closed Access
Screening of urate-lowering components in TongFengTangSan using an integrated strategy of affinity ultrafiltration, molecular docking and in vitro validation
Junying Wu, Qiong An, Zheng‐Gen Liao, et al.
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY (CHINESE VERSION) (2025), pp. 100551-100551
Open Access
Linking Hyperuricemia to Cancer: Emerging Evidence on Risk and Progression
Lingyun Zhao, Ruihong Guo, Ziming Zhao, et al.
Current Oncology Reports (2025)
Closed Access
Salinomycin, a potent inhibitor of XOD and URAT1, ameliorates hyperuricemic nephropathy by activating NRF2, modulating the gut microbiota, and promoting SCFA production
Yongjun Chen, Zitao Guo, Hai-Qiao Chen, et al.
Chemico-Biological Interactions (2024) Vol. 403, pp. 111220-111220
Closed Access | Times Cited: 3
Discovery of Novel Biphenyl Carboxylic Acid Derivatives as Potent URAT1 Inhibitors
Xianxin Hou, Yongcheng Wang, Yajun Yang, et al.
Molecules (2023) Vol. 28, Iss. 21, pp. 7415-7415
Open Access | Times Cited: 6
Synthesis and bioactivity evaluation of novel nuciferine derivatives with antihyperuricemia and nephroprotective effects
Yu-Kai Zhang, Jia‐Shu Chen, Minmin Wang, et al.
Bioorganic Chemistry (2022) Vol. 126, pp. 105916-105916
Closed Access | Times Cited: 10
Recent Updates of Natural and Synthetic URAT1 Inhibitors and Novel Screening Methods
Ying Chen, Ruya You, Ke Wang, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 11
Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial
Noelle Castilla‐Ojo, Ruth‐Alma Turkson‐Ocran, Paul R. Conlin, et al.
Journal of Clinical Hypertension (2023) Vol. 25, Iss. 10, pp. 915-922
Open Access | Times Cited: 4
Comparative efficacy and safety of uricosuric agents in the treatment of gout or hyperuricemia: a systematic review and network meta-analysis
Ya-Jia Li, Lirong Chen, Zhong-Lei Yang, et al.
Clinical Rheumatology (2022) Vol. 42, Iss. 1, pp. 215-224
Closed Access | Times Cited: 7
A Brief Review of Natural Products with Urate Transporter 1 Inhibition for the Treatment of Hyperuricemia
Qianghua Yuan, Yuan Cheng, Rong Sheng, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top